ANIK SG&A Expense Growth
Anika Therapeutics Inc · SG&A Expense Growth
ANIK SG&A Expense Growth
Latest reported-11.64%period ending
ANIK FY SG&A Growth (YoY) (0.00% → -11.64%)
Latest values, visible window
High-resolution chart · PNG
ANIK sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -11.6407% | |
| -7.2924% | |
| 16.9748% | |
| -30.8613% | |
| 23.3638% | |
| 71.8541% | |
| 1.7882% | |
| 59.4058% | |
| 19.5803% | |
| 21.5042% | |
| -1.6485% | |
| 16.5235% | |
| -12.1712% | |
| -17.526% | |
| 3.1233% | |
| 64.2209% | |
| -3.8315% | |
| 37.1238% | |
| 19.733% | |
| 23.4765% | |
| -10.4767% | |
| 43.5495% | |
| -4.8806% | |
| -28.7838% | |
| 48.361% | |
| 39.6015% | |
| 11.1111% | |
| 28.5714% | |
| -19.2308% | |
| 188.8889% | |
| 28.5714% | |
| -63.1579% | |
| 0% |